Concepedia

Lisa Hohnen

LH

Statistics

Publications

3

Citations

52

H-Index

3

Active since

2021

Affiliations

Max Planck Institute of Molecular Physiology(Current)

Chemical Genomics Centre

TU Dortmund University

Ruhr University Bochum

Broad Institute

Lisa Hohnen is an author at Max Planck Institute of Molecular Physiology specializing in drug discovery, small molecules, and natural sciences.

ORCID

Top concepts

Publications per year

2021–2023

3

Publications

3

Small molecules with tetrahydroquinoline-containing Povarov scaffolds as inhibitors disrupting the Protein–RNA interaction of LIN28–let-7

Georg L. Goebel, Lisa Hohnen, Lydia Borgelt et al. · European Journal of Medicinal Chemistry · 2021 · 27 citations

, , +7

Spirocyclic Chromenopyrazole Inhibitors Disrupting the Interaction between the RNA‐Binding Protein LIN28 and <i>Let‐7</i>

Lydia Borgelt, Fubao Huang, Lisa Hohnen et al. · ChemBioChem · 2023 · 13 citations · Full text

Chromenopyrazole−Peptide Conjugates as Small‐Molecule Based Inhibitors Disrupting the Protein−RNA Interaction of LIN28‐<i>let‐7</i>

Pascal Hommen, Jimin Hwang, Fubao Huang et al. · ChemBioChem · 2023 · 12 citations · Full text

1–3 of 3